Sponsor Pipeline

Exciva GmbH Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07284472 Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's… Agitation Associated With Alzheimer's Disease Dementia Recruiting
Disease Areas
Alzheimer's Disease (1) Dementia (1)
Get alerts when Exciva GmbH's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free